Clinical Research Directory
Browse clinical research sites, groups, and studies.
Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction
Sponsor: Comphya Inc.
Summary
The goal of this clinical trial is to assess if a new device is safe to use as a potential treatment for erectile dysfunction following radical prostatectomy. The main questions it aims to answer are: * Is the device safe? * Does the device works well? Are the participants satisfied with the device? Participants will be implanted with the device during the ongoing prostatectomy surgery and will be asked to complete the following tasks during 6 months follow-up: * Come to the hospital for follow-up visits, * Complete questionnaires, * Activate the device every day, * Measure erection hardness. Researchers will compare an implanted group (participants having the device) with a control group (participants not having the device) to see if the device works well.
Official title: Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
Key Details
Gender
MALE
Age Range
30 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2025-06-05
Completion Date
2027-04
Last Updated
2025-11-10
Healthy Volunteers
No
Interventions
Activation of pro-erectile nerves within the pelvic plexus
The study device is an active implantable device. The device activates the pro-erectile nerves by delivering electrical pulses. The daily delivery of electrical pulses to the pro-erectile nerves may allow participants to recover natural erectile function.
Locations (1)
Johns Hopkins Hospital
Baltimore, Maryland, United States